Claudia Schoch - Concepedia

Author

Claudia Schoch

Ludwig-Maximilians-Universität München

Also Known As

B. Wörmann, C Schoch, C. Fonatsch, C. Schoch, Claudia Schoch, Schoch C., Torsten Haferlach

333

Publications

17.5K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Munich Leukemia Laboratory (Germany)University of Göttingen University of Münster Heidelberg University

About

Claudia Schoch is an author at Ludwig-Maximilians-Universität München specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	55	5.7K
2	Health Sciences	14	16	1.4K
3	Engineering	4	4	188
4	Natural Sciences	4	4	212
5	Applied Physics	1	1	52

Claudia Schoch

127

Publications

15.5K

Citations

H-Index

Page 1

	Year	Citations
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease Susanne Schnittger, Claudia Schoch, Martin Dugas, Blood	2002	962
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy Andreas Hochhaus, Sebastian Kreil, A. Corbin, Leukemia ChromatinGenome InstabilityCell DivisionCytogeneticsChromatin Remodeling	2002	900
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype Susanne Schnittger, Claudia Schoch, Wolfgang Kern, Blood	2005	701
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia Thomas Pabst, Beatrice U. Mueller, Nari Harakawa, Nature Medicine Hematological MalignancyHematologyImmunologyPathologyMyelopoiesis	2001	462
Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease Marco Tartaglia, Simone Martinelli, Lorenzo Stella, The American Journal of Human Genetics Somatic VariantGenetic DisorderGeneticsPathogenesisFunctional Consequences	2006	420
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival Susanne Schnittger, Tobias Kohl, Torsten Haferlach, Blood	2005	378
AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases Claudia Schoch, Susanne Schnittger, Mirjam Klaus, Blood	2003	349
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann, PubMed	1999	321
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases Claudia Schoch, Susanne Schnittger, Sabina Bursch, Leukemia Hematological MalignancyChromatinChronic Myeloid LeukemiaOncologyCytogenetics	2002	309
Implications of NRAS mutations in AML: a study of 2502 patients Ulrike Bacher, Torsten Haferlach, Claudia Schoch, Blood	2006	298

Page 1